Publications:  Dr David Livermore

Livermore DM, Andrews JM, Hawkey PM, Ho P-L, Keness Y, Doi Y, Paterson D, Woodford N(2012). Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY vol. 67, (7) 1569-1577.

Beceiro A, Llobet E, Aranda J, Bengoechea JA, Doumith M, Hornsey M, Dhanji H, Chart H et al.(2011). Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother vol. 55, (7) 3370-3379.

Hornsey M, Loman N, Wareham DW, Ellington MJ, Pallen MJ, Turton JF, Underwood A, Gaulton T et al.(2011). Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother vol. 66, (7) 1499-1503.

Hornsey M, Ellington MJ, Doumith M, Thomas CP, Gordon NC, Wareham DW, Quinn J, Lolans K et al.(2010). AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother vol. 65, (8) 1589-1593.

Henderson-Begg SK, Sheppard CL, George RC, Livermore DM, Hall LMC(2010). Mutation frequency in antibiotic-resistant and -susceptible isolates of Streptococcus pneumoniae. INT J ANTIMICROB AG vol. 35, (4) 342-346.

Livermore DM, Hill RLR, Thomson H, Charlett A, Turton JF, Pike R, Patel BC, Manuel R et al.(2010). Antimicrobial treatment and clinical outcome for infections with carbapenem-and multiply-resistant Acinetobacter baumannii around London. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS vol. 35, (1) 19-24.

Bean DC, Livermore DM, Hall LMC(2009). Plasmids Imparting Sulfonamide Resistance in Escherichia coli: Implications for Persistence. ANTIMICROB AGENTS CH vol. 53, (3) 1088-1093.

Bean DC, Livermore DM, Hall LMC(2009). Plasmids imparting sulfonamide resistance in Escherichia coli: implications for persistence. Antimicrob Agents Chemother vol. 53, (3) 1088-1093.

Ellington MJ, Livermore DM, Pitt TL, Hall LMC, Woodford N(2006). Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli. CLIN MICROBIOL INFEC vol. 12, (8) 800-803.

Henderson-Begg SK, Livermore DM, Hall LMC(2006). Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J Antimicrob Chemother vol. 57, (5) 849-854.

Bean DC, Livermore DM, Papa I, Hall LMC(2005). Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man. J Antimicrob Chemother vol. 56, (5) 962-964.

Enne VI, Bennett PM, Livermore DM, Hall LMC(2004). Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective pressure. J ANTIMICROB CHEMOTH vol. 53, (6) 958-963.

Essack SY, Hall LMC, Livermore DM(2004). Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamases. INT J ANTIMICROB AG vol. 23, (4) 398-400.

SEFTON AM, Scott GM, Livermore DM(2003). Properties and potential of ertapemen. J Antimicrob Chemother vol. 52, 331-344.

HALL LMC, Livermore DM, Yuan M, Babini GS(2003). Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp with extended-spectrum beta-lactamases. J. Antimicrob. Chemother. vol. 51, 605-612.

Enne VI, King A, Livermore DM, Hall LMC(2002). Sulfonamide resistance in Haemophilus influenzae mediated by acquisition of sul2 or a short insertion in chromosomal folP. ANTIMICROB AGENTS CH vol. 46, (6) 1934-1939.

HALL LMC, Enne VI, Warner M, Livermore DM, Porjan SJ, Harrison G, Wooster SL, Dunman PM(2002). Antibiotic resistance in bacteria from magpies (Pica pica) and rabbits (Oryctolagus cuniculus) from west Wales. Environ. Microbiol. vol. 10, 658-661.

Koh TH, Sng LH, Babini GS, Woodford N, Livermore DM, Hall LMC(2001). Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein. ANTIMICROB AGENTS CH vol. 45, (6) 1939-1940.

HALL LMC, Enne VI, Stephens P, Livermore DM(2001). Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet vol. 357, 1325-1328.

Essack SY, Hall LMC, Pillay DG, McFadyen ML, Livermore DM(2001). Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. ANTIMICROB AGENTS CH vol. 45, (1) 88-95.

Yuan M, Hall LM, Hoogkamp-Korstanje J, Livermore DM(2001). SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, The Netherlands. Antimicrob Agents Chemother vol. 45, (1) 309-311.

HALL LMC, Livermore DM, Hoogkamp-Korstanje J, Yuan M(2001). SHV-14, a novel beta-lactamase variant in Klebsiella pneumoniae isolates from Nijmegen, the Netherlands. Antimicrob. Agents Chemother. vol. 45, 309-311.

Yuan M, Hall LM, Savelkoul PH, Vandenbroucke-Grauls CM, Livermore DM(2000). SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam. Antimicrob Agents Chemother vol. 44, (4) 1081-1084.

Koh TH, Babini GS, Woodford N, Sng LH, Hall LMC, Livermore DM(1999). Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. LANCET vol. 353, (9170) 2162-2162.

Danel F, Hall LM, Duke B, Gur D, Livermore DM(1999). OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa. Antimicrob Agents Chemother vol. 43, (6) 1362-1366.

Livermore DM(1997). Acquired carbapenemases. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY vol. 39, (6) 673-676.

IbrahimElmagboul IB, Livermore DM(1997). Sensitivity testing of ciprofloxacin for Pseudomonas aeruginosa. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY vol. 39, (3) 309-317.

YANG Y, JACOBY GA, LIVERMORE DM(1988). LXA-1 - A NEW PLASMID-MEDIATED BETA-LACTAMASE GIVING LOW-LEVEL RESISTANCE. FEMS MICROBIOLOGY LETTERS vol. 52, (1-2) 97-101.

LIVERMORE DM(1987). COVALENT TRAPPING AND LATAMOXEF RESISTANCE IN BETA-LACTAMASE-DEREPRESSED PSEUDOMONAS-AERUGINOSA. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY vol. 20, (1) 7-13.